RCEL Form 4: Director Robert McNamara acquires 10,000 shares

Rhea-AI Filing Summary

Avita Medical director Robert McNamara reported a personal purchase of company stock on 08/28/2025. The Form 4 shows a purchase of 10,000 shares of Avita Medical common stock at $4.50 per share. After the transaction he beneficially owns 86,771 shares, a figure the filing notes includes unvested restricted stock units. The filing identifies McNamara as a director and was signed by an authorized power of attorney on 08/29/2025. The document lists no derivative transactions and provides no additional financial results or forward-looking statements.

Positive

• Director purchase recorded: Acquisition of 10,000 shares at $4.50 per share indicates an insider buy.
• Transparent beneficial ownership disclosure: Filing states post-transaction ownership of 86,771 shares and clarifies inclusion of unvested RSUs.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 10,000 shares at $4.50, increasing reported beneficial holdings to 86,771 shares.

This Form 4 documents a routine insider purchase rather than a sale or option exercise. The purchase price of $4.50 per share and the post-transaction beneficial ownership number are explicit; the filing also clarifies that the total includes unvested RSUs, which affects voting and economic rights until vesting. For investors, insider purchases can signal confidence but the form alone does not quantify materiality relative to total outstanding shares or disclose intent beyond the transaction itself.

Corporate Governance Expert

TL;DR: Reporting person is a director and reported acquisition via Form 4; filing was executed via power of attorney.

The filing correctly identifies the reporting person as a director and notes the Form 4 was signed by a named attorney-in-fact, which is standard practice. The inclusion of unvested RSUs in the beneficial ownership total is explicitly disclosed, which is important for governance transparency. The document contains no indication of related-party transactions, accelerated vesting, or amendments that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McNamara Robert

(Last) (First) (Middle)

C/O AVITA MEDICAL 28159 AVENUE STANFORD

SUITE 220

(Street)

VALENCIA CA 91355

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		P		10,000	A	$4.5	86,771(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes unvested RSUs

	/s/ Nicole Kelsey, by power of attorney	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Avita Medical director Robert McNamara report on Form 4 (RCEL)?

He reported purchasing 10,000 shares of Avita Medical common stock on 08/28/2025 at $4.50 per share and now beneficially owns 86,771 shares.

Does the filing indicate whether the 86,771 shares are fully vested?

No; the Form 4 explicitly states that the 86,771 total includes unvested restricted stock units (RSUs).

Was the Form 4 signed by Robert McNamara personally?

No; the signature block shows the form was signed by Nicole Kelsey by power of attorney on 08/29/2025.

Are there any derivative transactions reported in this Form 4?

No; the filing lists only a non-derivative purchase of common stock and no options, warrants, or other derivative securities.

What transaction date is listed on the Form 4?

08/28/2025 is shown as the transaction date for the purchase.